Orange Book product · Generic (ANDA)
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
HYDROCHLOROTHIAZIDE; TRIAMTERENE
At a glance
Jan 28, 2025
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 28, 2025
1 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
HYDROCHLOROTHIAZIDE; TRIAMTERENE
Strength
25MG;37.5MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
ANDA 214611
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HYDROCHLOROTHIAZIDE; TRIAMTERENE
- 1994DYAZIDEBrand (NDA)
NDA 016042 · GLAXOSMITHKLINE LLC
- 1984MAXZIDEBrand (NDA)
NDA 019129 · AUROBINDO PHARMA USA
- 2022TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 216211 · RUBICON RESEARCH
- 2019TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 208358 · CADILA
- 2018TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 208360 · ZYDUS PHARMS
- 2011TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 201407 · LANNETT CO INC
- 1999TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 075052 · DURAMED PHARMS BARR
- 1998TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 071251 · APOTEX INC
- 1998TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 074970 · ANI PHARMS
- 1997TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 074857 · NOVARTIS
- 1997TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 074821 · SANDOZ
- 1996TRIAMTERENE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 074701 · PHARMOBEDIENT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
